Arovella Therapeutics: Why is everyone talking “immunotherapy” for cancer?

Listen to ASX-listed Arovella Therapeutics Managing Director Dr Michael Baker talk to Matt Birney on the Bulls N’ Bears Report about Arovella’s amazing technology that can temporarily remove blood cells from the body and reprogram them to seek and destroy cancer cells before being reinserted.

See omnystudio.com/listener for privacy information.